Pacific Hospital Supply Co Ltd

Pacific Hospital Supply Co Ltd maintains a strong liquidity position, with a current ratio of 3.49, indicating the company can cover its short-term liabilities more than three times over. However, the company has a negative net cash position after subtracting total debt, which may raise concerns about its liquidity risk. The price-to-book ratio of 1.96 and a price-to-tangible-book ratio of 1.96 suggest that the company is trading at a premium to its book value, which may reflect investor confidence in its future earnings potential. In terms of profitability, the company's return on equity (ROE) of 12.9% and return on assets (ROA) of 9.77% are strong indicators of efficient use of equity and assets to generate profits. These figures are well above the typical thresholds for the medical equipment and supplies industry, suggesting that the company is outperforming its peers in terms of capital efficiency and profitability. The company's revenue is distributed across multiple geographic regions, with a focus on Taiwan, Japan, China, Europe, Australia, America, Southeast Asia, and the Middle East. This geographic diversification helps mitigate the risk of over-reliance on any single market. However, the company's revenue concentration in these regions may still expose it to regional economic fluctuations and regulatory changes. Looking at the company's growth trajectory, the financial data does not provide forward-looking revenue projections. However, the company's operating cash flow of 542,086,000 TWD and free cash flow of 77,525,000 TWD indicate a positive cash flow generation, which supports its ability to fund operations and invest in growth opportunities. The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The negative net cash position after subtracting total debt is a key flag, suggesting that the company may need to raise additional capital or manage its debt more effectively to maintain its liquidity position. The company's debt-to-equity ratio of 0.14 is relatively low, indicating a conservative capital structure with minimal leverage. Recent events, such as analyst estimates, show a mean recommendation of 3.00, which is a "Hold" rating. This suggests that analysts are neutral on the stock, with no strong buy or sell recommendations. The last actual EPS was 5.24 TWD, and the last actual revenue was 2,405,903,000 TWD, indicating stable performance in the most recent reporting period.